Welcome to our dedicated page for Global Medical SEC filings (Ticker: GMRE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Global Medical REIT Inc. (GMRE) SEC filings page provides direct access to the company’s regulatory disclosures, along with AI-assisted summaries to help interpret complex documents. As a net-lease medical real estate investment trust, GMRE files annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K that describe its healthcare real estate portfolio, lease structures, financing arrangements and governance matters.
In these filings, Global Medical REIT details its rental revenue, net income or loss, Funds From Operations (FFO), Adjusted Funds From Operations (AFFO), Funds Available for Distribution (FAD), Earnings Before Interest, Taxes, Depreciation and Amortization for Real Estate (EBITDAre and Adjusted EBITDAre), Net Operating Income (NOI), cash NOI and same-store cash NOI. The company also discloses portfolio occupancy, leasable square footage, annualized base rent, lease expiration schedules and the mix of outpatient medical buildings, inpatient rehabilitation facilities, hospitals and other medical real estate. Our AI tools highlight how these metrics are calculated and what they imply for operating performance and leverage.
Recent Form 8-K filings for GMRE include disclosures about amendments and restatements of its credit facility, including extended maturities for its revolver and term loans and the removal of a SOFR credit spread adjustment, as well as the use of forward-starting interest rate swaps to hedge term loan exposure. Other 8-Ks describe the authorization and mechanics of a one-for-five reverse stock split, the approval of a common stock repurchase program, the appointment of a new Chief Executive Officer and President, and the planned retirement of a long-serving independent director.
Filings also cover capital markets transactions such as the underwriting agreement for GMRE’s 8.00% Series B Cumulative Redeemable Preferred Stock and related Articles Supplementary and partnership agreement amendments. Through this page, users can review Forms 3, 4 and 5 for insider ownership and trading activity, as well as proxy materials that discuss executive compensation and board structure when available. Real-time updates from the SEC’s EDGAR system, combined with AI-generated explanations, make it easier to understand how Global Medical REIT’s filings relate to its portfolio strategy, capital structure and dividend practices.
Form 3 filing overview: Global Medical REIT Inc. (GMRE) submitted an Initial Statement of Beneficial Ownership (Form 3) on 25 June 2025 for Mark Okey Decker Jr., who is listed as both Director and President & CEO.
Key details
- Date of event: 23 June 2025
- Securities owned: None – the filing explicitly states “No securities are beneficially owned.”
- Signatory: /s/ Jamie Barber acting under Power of Attorney dated 23 June 2025.
The document satisfies Section 16(a) initial reporting requirements and indicates the new executive currently holds zero GMRE common shares or derivative securities, leaving open the possibility of future insider acquisitions that would require subsequent Form 4 disclosures.
Global Medical REIT Inc. (NYSE: GMRE) filed an 8-K disclosing a CEO transition effective 23 Jun 2025. Jeffrey M. Busch has been removed as Chief Executive Officer and President and will remain non-executive Chairman. The Board simultaneously appointed Mark O. Decker, Jr. (age 49) as CEO, President and Board member, expanding the Board from seven to eight seats.
The filing provides a detailed three-year employment agreement between Inter-American Management LLC and Mr. Decker:
- Base salary: $700,000 per year.
- Target annual cash bonus: ≥100 % of base salary, prorated for 2025 (60 % cash / 40 % LTIP Units).
- Equity incentives: one-time $1 million LTIP award on the Effective Date; $1.2 million target LTIP award for 2026.
- Relocation stipend: $75,000.
Severance for a "Qualifying Termination" equals 2× (base salary + greater of target or prior-year bonus), pro-rated bonus, accelerated vesting of equity, and up to 18 months of subsidized health coverage. Enhanced benefits (up to 3× multiplier) apply upon qualifying terminations linked to a change in control. Definitions of "good reason" and "cause" are standard for REIT executives.
Mr. Decker’s prior roles include Managing Partner at Proterra Value Investors (2023-2025) and CEO/CIO of Centerspace (NYSE: CSR, 2017-2023). The filing states no family relationships or related-party transactions.